REFERENCES
1 Liu Z, Doan Q V., Blumenthal P, Dubois RW. A systematic review
evaluating health-related quality of life, work impairment, and
health-care costs and utilization in abnormal uterine bleeding. Value
Heal. 2007; 10 : 183–94.
2 Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding
significantly affects quality of life. Acta Obstet Gynecol Scand2014; 93 : 52–7.
3 Duckitt K. Managing perimenopausal menorrhagia. Maturitas. 2010;66 : 251–6.
4 Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F.
Prevalence of heavy menstrual bleeding and experiences of affected women
in a European patient survey. Int J Gynecol Obstet 2015;128 : 196–200.
5 Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems
for normal and abnormal uterine bleeding symptoms and classification of
causes of abnormal uterine bleeding in the reproductive years: 2018
revisions. Int J Gynecol Obstet 2018. DOI:10.1002/ijgo.12666.
6 National Collaborating Centre for W, Children’s H. National Institute
for Health and Clinical Excellence: Guidance. In: Heavy Menstrual
Bleeding. 2007.
7 Marret H, Fauconnier A, Chabbert-Buffet N, et al. Clinical
practice guidelines on menorrhagia: Management of abnormal uterine
bleeding before menopause. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010;152 : 133–7.
8 Cooper K, Lee AJ, Chien P, Raja EA, Timmaraju V, Bhattacharya S.
Outcomes following hysterectomy or endometrial ablation for heavy
menstrual bleeding: Retrospective analysis of hospital episode
statistics in Scotland. BJOG An Int J Obstet Gynaecol 2011.
DOI:10.1111/j.1471-0528.2011.03011.x.
9 Kroft J, Liu G. First-Versus Second-Generation Endometrial Ablation
Devices for Treatment of Menorrhagia: A Systematic Review, Meta-Analysis
and Appraisal of Economic Evaluations. J Obstet Gynaecol Canada2013; 35 : 1010–9.
10 Lethaby A, Penninx J, Hickey M, Garry R, Marjoribanks J. Endometrial
resection and ablation techniques for heavy menstrual bleeding. Cochrane
Database Syst. Rev. 2013; 2013 .
DOI:10.1002/14651858.CD001501.pub4.
11 Daniels JP, Middleton LJ, Champaneria R, et al. Second
generation endometrial ablation techniques for heavy menstrual bleeding:
network meta-analysis. BMJ. 2012; 344 . DOI:10.1136/bmj.e2564.
12 Cooper K, McCormack K, Breeman S, et al. HEALTH: Laparoscopic
supracervical hysterectomy versus second-generation endometrial ablation
for the treatment of heavy menstrual bleeding: Study protocol for a
randomised controlled trial. Trials 2018.
DOI:10.1186/s13063-017-2374-9.
13 Fernandez H, Kobelt G, Gervaise A. Economic evaluation of three
surgical interventions for menorrhagia. Hum Reprod 2003;18 : 583–7.
14 Cooper K, Breeman S, Scott NW, et al. Laparoscopic
supracervical hysterectomy compared with second-generation endometrial
ablation for heavy menstrual bleeding: The HEALTH RCT. Health
Technol Assess (Rockv) 2019. DOI:10.3310/hta23530.
15 Roberts TE, Tsourapas A, Middleton LJ, et al. Hysterectomy,
endometrial ablation, and levonorgestrel releasing intrauterine system
(Mirena) for treatment of heavy menstrual bleeding: Cost effectiveness
analysis. In: BMJ (Online). 2011. DOI:10.1136/bmj.d2202.
16 Garside R, Stein K, Wyatt K, Round A, Pitt M. A cost-utility analysis
of microwave and thermal balloon endometrial ablation techniques for the
treatment of heavy menstrual bleeding. BJOG An Int J Obstet
Gynaecol 2004; 111 : 1103–14.
17 Bischoff-Everding C, Soeder R, Neukirch B. Economic and clinical
benefits of endometrial radiofrequency ablation compared with other
ablation techniques in women with menorrhagia: A retrospective analysis
with German health claims data. Int J Womens Health 2016;8 : 23–9.
18 Miller JD, Lenhart GM, Bonafede MM, Basinski CM, Lukes AS, Troeger
KA. Cost effectiveness of endometrial ablation with the NovaSure® system
versus other global ablation modalities and hysterectomy for treatment
of abnormal uterine bleeding: US commercial and medicaid payer
perspectives. Int J Womens Health 2015; 7 : 59–73.
19 Bezin J, Duong M, Lassalle R, et al. The national healthcare
system claims databases in France, SNIIRAM and EGB: Powerful tools for
pharmacoepidemiology. Pharmacoepidemiol Drug Saf 2017;26 : 954–62.
20 WHO. International Statistical Classification of Diseases and Related
Health Problems (International Classification of Diseases)(ICD) 10th
Revision - Version:2010. 2010.
21 de Léotoing L, Chaize G, Fernandes J, et al. The surgical
treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000
patients from the French exhaustive national hospital discharge database
from 2009 to 2015. PLoS One 2019.
DOI:10.1371/journal.pone.0217579.